News of Pharmaceuticals | Healthcare | Wellness in Gujarat

Alembic gets USFDA nod to market eye-infection treatment

VADODARA (BARODA) | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Friday, Gujarat (Vadodara – Baroda) headquartered pharma company Alembic Pharmaceuticals Ltd said of  the Company having received US Food & Drug Administration (USFDA) Approval for Azelastine Hydrochloride Ophthalmic Solution, 0.05%. Azelastine Hydrochloride Ophthalmic Solution, 0.05%, has an estimated

After inspection, USFDA classifies Jubilant Life Sciences’ Nanjangud facility

NANJANGUD | NOIDA | MUMBAI | RAJKOT – Jubilant Lifesciences Limited (JLL), an integrated global pharmaceuticals and life sciences company, has been informed by the U.S. Food and Drug Administration (USFDA), in correspondence dated March 13, 2019, received today, that the inspection from December 10-18, 2018 at the Jubilant Generics Limited (JGL) (FEI: 3003144728) API

GRANULES INDIA promoters sell 5 million shares

HYDERABAD | MUMBAI | RAJKOT – In a press release submitted to the Stock Exchanges in India, Hyderabad headquartered pharma company Granules India Ltd said of having sold 5 million (50 lakh) shares to a group of reputed investors in a block deal on the stock exchanges, to mobilize about 500 million (50 crore) rupees.

SUVEN LIFE to acquire US based RISING PHARMA

HYDERABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Friday, Hyderabad headquartered Suven Life Sciences Ltd announces the asset purchase agreement for acquiring Aceto Corporation’s New Jersey (US) headquartered Rising Pharmaceuticals through its joint venture partner, Shore Suven Pharma Inc. The acquisition will be subject to Court-approved bidding

USFDA inspects Strides Pharma’s Bengaluru facility, gets EIR with Zero 483 Observations

BANGALURU | MUMBAI | RAJKOT – US FDA (Food & Drugs Administration) successfully inspected Strides Pharma Sciences Ltd’s formulations facility (KRSG Gardens) in  Bengaluru and the facility has  received the Establishment Inspection Report (EIR), there by confirming the successful  closure of the inspections, the company said in Press Release submitted to the Indian Stock Exchanges

#DLGGujaratConnect | VIAGRA Manufacturer – “Pfizer” shuts Aurangabad & Chennai units in India, impacting 1,700 jobs

MUMBAI | AURANGABAD | CHENNAI | NEW DELHI | AHMEDABAD | RAJKOT –  Following a thorough evaluation of the Aurangabad (Maharashtra) and Irungattukottai (Tamilnadu) plant, Pfizer Ltd has finally decided to shutdown the two facilities in India, on grounds of long-term loss of product demand, making manufacturing at this sites “unviable”, the three page handout

Zydus Cadila gets USFDA nod to market drugs to treat cholesterol and body tissues

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Exchanges in India, Ahmedabad headquartered and Dr Pankaj Patel led Cadila Healthcare Ltd (Zydus Cadila Group) said of having got US Food & Drugs Administration’s nod to market drug two drugs, one to control cholesterol as well another to treat abnormal hardening

Zydus Cadila gets USFDA nod to market drug to treat excess iron levels in human blood

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Exchanges on Tuesday, Ahmedabad headquartered and Pankaj Patel owned Cadila Healthcare (Zydus Cadila Group) said of having got US Food and Drugs Administration nod to market drug to treat excess iron levels in human blood. Zydus Cadila has received the tentative

Alembic Pharma gets USFDA nod to market erectile dysfunction treatment drug

VADODARA (BARODA) | MUMBAI | RAJKOT – In a press release submitted to the Exchanges in India on Tuesday, Alembic Pharma said of having got approval from US Food & Drugs Administration to market erectile dysfunction treatment tablets, the product has an estimated market-size of US $ 8 million over period of 12 months. Alembic

US FDA issues form 483 to Alembic Pharma’s Panelav facility for oral solids

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update filed to the Indian Bourses on Friday, Alembic Pharmaceuticals Ltd said of having got their Panelav facility manufacturing general oral solids inspected by US FDA (Food & Drugs Administration) and the regulator having slammed Form 483 to the facility, after inspection. The United States

Zydus Cadila gets US FDA nod to market drug for treatment of epilepsy

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Tuesday, Cadila Healthcare Ltd (Dr Pankaj Patel owned Zydus Cadila group) said of having availed regulatory approval from US Food and Drugs Administration (USFDA) to market drug to treat epilepsy. Zydus Cadila has received the final approval from the

USFDA successfully inspects Alembic’s JV facility Aleor Derma

VADODARA (BARODA) | MUMBAI | RAJKOT – In a press release submitted to the Exchanges in India on Monday, in wee hours before the trading session kicked-off on the Indian Bourses, Alembic Pharmaceuticals Ltd said of Aleor Dermaceuticals Ltd’s facility, getting successfully inspected by USFDA. Aleor Dermaceuticals Ltd. (Aleor), a 60:40 Joint Venture between Alembic

Zydus Cadila gets US FDA nod to market anti-arthritis drug

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory filing submitted to the Indian Bourses on Thursday, Ahmedabad headquartered and Dr Pankaj Patel led Cadila Healthcare Ltd (Zydus Cadila Group) said of having received regulatory approvals from US FDA (Food & Drugs Department) to market anti-arthritis drug. Zydus Cadila has received the tentative approval from

Zydus Cadila gets US FDA nod to market skin-care ointment

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the exchanges in India on Wednesday, Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) said of having got approval from US FDA (Food & Drugs Administration) to market skin-care ointment. Zydus Cadila has received the final approval from the USFDA to

Alembic gets US FDA nod to market diet-exercise equivalent pill, for diabetics

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory filing submitted on Tuesday, Vadodara headquartered and Amin family owned Alembic Pharma said of having got approval from US FDA (Food & Drugs Administration) to market diet and exercise equivalent pill for diabetic patients. Alembic Pharmaceuticals Limited today announced that the company has received tentative

Lincoln Pharma invests in renewable energy assets to save on energy cost

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Bourses on Monday, Ahmedabad headquartered Lincoln Pharmaceuticals Ltd said of having invested in renewable energy assets to save on energy cost and improve financials, as well having applied for permission to set-up Active Pharmaceuticals Ingredients (API) manufacturing unit. The Company has